Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 3, 2008, Pages 461-466

  Srifuengfung, Somporn ^a   Tribuddharat, Chanwit ^a,d   Champreeda, Preecha ^b   Daniels, Justin ^b   Chokephaibulkit, Kulkanya ^c   Wongwan, Nithita ^a   Polwichai, Pitimon ^a  

^a Department of Microbiology ^*

^b GLAXOSMITHKLINE   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44949226986     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bruinsma N, Kristinsson KG, Bronzwaer S, et al. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother 2004; 54: 1045-50.
2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Wayne, Pennsylvania: CLSI, 2006; 26, M100-S16.
3. Felmingham D, Grunebergand RN, the Alexander project group. The Alexander project 1996-1997: latest susceptibility data from the international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
4. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN, the Alexander project group. The Alexander project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229-46.
5. Johnson DM, Stilwell MG, Pritsche TR, Jones RN. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY antimicrobial surveillance program (1999-2003). Diagn Microbiol Infect Dis 2006; 56: 69-74.
6. Kelley MA, Weber DJ, Gilligan P, Cohen MS. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis 2000: 31: 1008-11.
7. Kimura T, Horii T, Morita M, Muramatsu H, Kanno T, Maekawa M. Detection of macrolide resistance in Streptococcus pneumoniae. Chemotherapy 2003; 49: 56-61.
8. Palavecino EL, Riedel I, Duran C, et al. Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile, Int J Antimicrob Agents 2002: 20:108-12.
9. Perez-Trallero E, Fermandez-Mazarrasa C, Garcia-Rey C, et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001; 45: 3334-40.
10. Reinert RR, Reinert S, Linden M, Cil MY, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903-13.
11. th ed. Washington DC: American Society for Microbiology, 2003: 405-21.
12. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother 2000; 45: 457-66.
13. Schito GC, Felmingham D. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003). Int J Antimicrob Agents 2005: 26: 479-85.
14. rd ed. New York: John Wiley and Sons, 2001.
15. Soh SW, Poh CL, Lin RP. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated from pediatric patients in Singapore. Antimicrob Agents Chemother 2000; 44: 2193-6.
16. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004; 48: 2101-7.